Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Prostate cancer
Closed
Phase 2
This trial is for men with prostate cancer that has continued to grow or spread (metastatic cancer) despite hormone treatment.
It is for men who either:
have had chemotherapy with a drug called docetaxel
have had hormone treatment with a drug called enzalutamide. And haven't had chemotherapy with docetaxel
Recruitment start: 15 August 2016
Recruitment end: 6 December 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Johann de Bono
Merck Sharp & Dohme Ltd
Last reviewed: 19 Dec 2018
CRUK internal database number: 14231